
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Exclusive survey : How do you measure up? Puzzler : Strep throat, torticollis in 8-year-old girl Dermcase : Infant with swollen fingers The care of lines and tubes in children






